Market Access Director

Deciphera, a member of ONO, is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines.

Enabled by our proprietary drug discovery platform, Deciphera has developed a diverse pipeline of wholly-owned drug candidates. QINLOCK (ripretinib) is Deciphera's switch control inhibitor developed for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United States, and the United Kingdom. We wholly own QINLOCK and all of our drug candidates with the exception of a development and commercialization out-license agreement for QINLOCK in Greater China. In addition to QINLOCK, we have identified and advanced multiple product candidates from our platform into clinical studies, including vimseltinib and DCC-3116.

We offer an outstanding culture and opportunity for personal and professional growth guided by our "PATHS" Core Values and how we work together. We are proud to be Great Place to Work Certified 2023 and rank on Fortune's Best Places to Work Small and Midsized Biotech Companies in 2023.

Job Description

We are seeking a Market Access Director to lead our efforts in evidence generation for the cost-effectiveness archetype markets in Europe while also supporting our International expansion. Your strong experience in building and executing market access strategies and tactics will support us to establish a globally aligned market access pathway. As Deciphera we are dedicated to enable patients access to our innovative products and our promising pipeline.

This position will report to the VP Market Access International. The location of the position is in the United Kingdom.

What You'll Do:

• Establish Deciphera as credible stakeholder with Health Authorities (NICE, SMC, NHS England, NHS Scotland, etc.)
• Lead the Pricing and Reimbursement strategy and processes for UK
• Inform International and European Market Access Strategy with UK insights and priorities
• Lead the Development of the Strategic HTA evidence base for commercial and/or late stage assets in collaboration with Medical and HEOR
• Lead Strategic and Operational Pricing and Reimbursement Submissions for Cost-Effectiveness archetype markets
• Ensure Cost-Effectiveness Archetype priorities are reflected within clinical development strategy as well as within Market Access and Pricing strategies.
• Lead European RWE strategy and execution that are essential for market access success of commercial and late stage assets
• Provide input and have a seat on the International and Global cross-functional program/workstream teams
• Support International market access efforts with HTA evidence adaptation and expertise where needed
• Support and be part of the development for best-in-class market access organization
• Ad-hoc lead or support on various functional priorities/projects

Qualifications

What You'll Bring:

• University degree, MBA or PhD in science and/or economics preferred
• Demonstrated experience leading the development of strategic HTA evidence and including cost-effectiveness archetypes in several stages
• Hands-on experience with HTA
• Demonstrated knowledge of market access trends, tactics, and UK as well as European dynamics
• Demonstrated knowledge in at least one of the core market access domains (pricing, HEOR, policy, local market execution)
• Experience and proven success working with cross-functional teams across geographies
• Demonstrated success in managing multiple activities (both "self" and through delegation) and working in a fast-paced environment
• Oncology experience is a plus
• Fluency in both written and oral English is essential
• Excellent ability to see the 'bigger picture' in market access and work across domains
• Ability to manage ambiguity, frequent change and senior level engagements; Ability to confidently seek out help when needed
• Strong strategic, tactical and operational skills and ability and willingness to switch between strategic and operational level of working
• Strong learning agility and ability to engage in-depth across multiple disease areas
• Clear ability to work across cultures, languages, and geographies and willingness to travel frequently, as the business requires

Additional Information

Deciphera offers a comprehensive benefits package that includes but is not limited to the following:

• Non-accrual paid time off
• Summer vacation bonus
• Global, company-wide summer and winter shutdowns
• Monthly cell phone stipend
• Internal rewards and recognition program
• Medical, Dental, and Vision Insurance
• 401(k) retirement plan with company match
• Life and Supplemental life insurance for family
• Short and Long Term Disability insurance
• Health savings account with company contribution
• Flexible spending account for either health care and/or dependent care.
• Family planning benefit
• Generous parental leave

Deciphera, a member of ONO, is a company headquartered in Waltham, Massachusetts. Our state-of-the-art research facility is located in Lawrence, Kansas and our European operations are run out of Switzerland.

EQUAL EMPLOYMENT OPPORTUNITY INFORMATION

Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements and to learn more about how we can increase diversity in our candidate pool, we invite you to voluntarily provide demographic information in a confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process and has no effect on your opportunity for employment. This information will also be treated confidentially. Our commitment to increasing diversity in our candidate pool does not affect our commitment to equal employment opportunity, including our ongoing commitment to make all hiring and other employment decisions solely on a nondiscriminatory basis.